Revolutionizing Gynecology: Aspivix’s Carevix Redefines Patient Comfort
In the world of gynecology, a groundbreaking innovation is transforming the way procedures like IUD insertions and cervical biopsies are performed.Meet Carevix, a revolutionary device developed by the Swiss startup Aspivix, which is redefining patient comfort and safety.
The Problem with Conventional Tools
For decades, gynecologists have relied on the cervical tenaculum, a scissor-like instrument invented in 1846, to manipulate and stabilize the cervix during procedures. While effective, this tool often causes significant pain and bleeding, deterring many women from opting for iuds as a contraceptive method. In fact, studies show that 20% to 30% of women avoid IUDs due to fear of pain associated with the tenaculum.
A Modern Solution: Carevix
aspivix, a Vaudois startup founded by two brothers and a businessman, has introduced Carevix, a single-use, non-invasive device that replaces the traditional tenaculum. Designed with soft suction technology, Carevix resembles an electric toothbrush with a piston and a long tube that gently stabilizes the cervix.
Clinical tests have shown remarkable results: a 73% reduction in pain during IUD insertions and an 83% decrease in bleeding during or after procedures. To date, 1,300 women worldwide have benefited from Carevix, with overwhelmingly positive feedback.
Recognition and Market Impact
Carevix’s innovative design has earned it a spot among TIME Magazine’s 200 Best Inventions of 2024. The device has been validated by health authorities in Switzerland, Europe, the United kingdom, Brazil, and the United States, making it a globally recognized solution for gynecological procedures.Aspivix has also successfully raised funds through the International collaborative Investment Platform Capital Cell, aiming to secure over €2.15 million by March 15. As of Tuesday morning, nearly 140 investors had already committed, covering 96% of the target capital.
Why Carevix Matters
By addressing the pain and discomfort associated with traditional tools,carevix is empowering women to choose IUDs without fear. This innovation not only enhances patient comfort but also reaffirms the IUD’s place as a reliable contraceptive method.
| Key Highlights of Carevix |
|——————————-|
| Pain Reduction | 73% reduction during IUD insertions |
| Bleeding Reduction | 83% decrease during or after procedures |
| global Validation | Approved in Switzerland, Europe, UK, Brazil, and the US |
| Investor Interest | 96% of €2.15 million target raised |
Aspivix’s Carevix is more than just a medical device—it’s a testament to the power of innovation in improving women’s health. As it continues to gain traction, this groundbreaking tool is set to redefine gynecological care worldwide.For more details on Aspivix and their revolutionary work, visit their official website here.
